Your browser doesn't support javascript.
loading
Epstein-Barr virus-associated lymphoproliferative disease during imatinib mesylate treatment for chronic myeloid leukemia.
Yamaguchi, Junko; Fujino, Takahiro; Isa, Reiko; Nishiyama, Daichi; Kuwahara-Ota, Saeko; Kawaji, Yuka; Tsukamoto, Taku; Chinen, Yoshiaki; Shimura, Yuji; Kobayashi, Tsutomu; Horiike, Shigeo; Kohno, Kei; Nakamura, Shigeo; Kuroda, Junya.
Afiliação
  • Yamaguchi J; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto.
  • Fujino T; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto.
  • Isa R; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto.
  • Nishiyama D; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto.
  • Kuwahara-Ota S; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto.
  • Kawaji Y; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto.
  • Tsukamoto T; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto.
  • Chinen Y; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto.
  • Shimura Y; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto.
  • Kobayashi T; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto.
  • Horiike S; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto.
  • Kohno K; Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan.
  • Nakamura S; Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan.
  • Kuroda J; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto junkuro@koto.kpu-m.ac.jp.
Haematologica ; 104(8): e376-e379, 2019 08.
Article em En | MEDLINE | ID: mdl-30975907
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Herpesvirus Humano 4 / Infecções por Vírus Epstein-Barr / Inibidores de Proteínas Quinases / Mesilato de Imatinib / Transtornos Linfoproliferativos Tipo de estudo: Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Revista: Haematologica Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Herpesvirus Humano 4 / Infecções por Vírus Epstein-Barr / Inibidores de Proteínas Quinases / Mesilato de Imatinib / Transtornos Linfoproliferativos Tipo de estudo: Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Revista: Haematologica Ano de publicação: 2019 Tipo de documento: Article